ocr: TABLE 44.6-6. Combined Chemotherapy and Radiation Therapy Versus Wide-Field Radiation Therapy Alone Pathologic Study Stage Design (No. of Patients) FFR 0) Stanford University261 IA-IIA IF+ MOPP (36) VS STLI or TLI (35) 83% VS 66% (9) Stanford University261 IB-IIB TLI + MOPP (35) VS TLI (28) 76% VS 73% (15) Danish National Study273 I-II M+ MOPP (133) vs: STLI/TLI (128) 90% VS 67% (7)* Southwest Oncology Group270 I-II IF+) MOPP (120) Vs STLI (115) 82% VS 71% (8)* Manchester Lymphoma-0 I-II M+N MVPP (59) vs M (56) 91% VS 67% (10jt FFR, freedom from relapse (in some studies, this refers to freedom ...